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Abstract: 
An elevation of serum cholesterol has been one of the more frequently cited risk factors for coronary heart 
disease, found in both case-control and cohort studies. As a result, this country has undertaken massive 
screening of adults older than 20 years of age in an attempt to identify those persons with cholesterol levels 
greater than 200 mg/dl, and follow up with an active approach for intervention. The suggested cutpoints for 
borderline (200-240 mg/dl), and definite (≥240 mg/dl) hypercholesterolemia have been applied to all age groups 
despite suggestions of a diminution of risk conferred by cholesterol in the elderly. This study of 2544 white men 
undergoing coronary angiography shows that for all men, aged 25-84 years, plasma cholesterol levels were 
associated with an increase in coronary artery occlusion (rs = 0.15, p < 0.01). However, when stratified by age, 
this association held only for the younger men, the association diminishing to near zero in the oldest age group. 
The negative interaction between cholesterol levels and age in predicting coronary artery disease proved highly 
significant (p <0.00)) in multivariable linear regression analysis, suggesting that cholesterol levels are much less 
predictive of coronary artery disease in the elderly as compared to the young. These results point to the need for 
a more finely tuned set of criteria for the evaluation of hypercholesterolemia, one that takes into account the age 
of the screenee. 





Of the risk factors that increase the risk for coronary heart disease (CHD), serum cholesterol is among the most 
frequently cited in the literature. This relation has been shown in numerous case-control and cohort studies. As 
a result, this country has undertaken mass efforts to screen its population for persons with elevated lipid levels 
with hopes of preventing or delaying the onset of CHD [1]. To obtain these goals, it has been suggested that 
men and women at least 20 years of age who have total cholesterol levels of ≥200 mg/dl evaluated for risk of 
CHD. Further, for persons with cholesterol levels ≥240 mg/dl, an intensive intervention program should be 
initiated, involving a stepped approach starting with dietary interventions and progressing to drug therapy. 
While an admirable goal, the consequences of such programs have come into question [2]. The value of the 
suggested approach of predetermined cut-points for referral and therapy for men and women of all ages is 
especially questionable. While the relationship between total cholesterol and subsequent coronary events 
appears to hold for young to middle-aged men, there have been suggestions that this relationship may change in 
importance in different age groups. 
 
The Framingham Study found that total cholesterol levels were less predictive of overt CHD in older men and 
women as compared to younger [3-7]. However, subfractions of serum cholesterol, in the high density 
lipoproteins (HDL) and low density lipoproteins (LDL), remained predictive for CHD events in both men and 
women over the age of 50. This diminution of risk has been found in other samples using CHD as an endpoint 
[9-11], and in studies of more restricted endpoints as well [12, 13]. Case—control studies have reported similar 
diminutions of risk imparted by total cholesterol levels [15, 16]. The timing of the measurement of cholesterol 
may be important but the age-related decrease in risk has been found in cross-sectional studies [14, 15] where 
cholesterol levels are measured at or near the time of the event as well as in studies measuring lipids 5 [5, 6, 13] 
to 10 or more years [10, 12, 16] previously. 
 
However, not all studies have shown this attenuation of risk. Other observations have ranged from no 
association of cholesterol level with CHD [16], to consistent positive associations across age strata [17-20]. One 
further study noted that the crude association between total cholesterol and death from ischemic heart disease 
was not significant in men over the age of 65 [21]. However, after controlling for other risk factors, a one 
standard deviation increase in total cholesterol imparted a statistically significant 1.4-fold increase in risk for 
death from ischemic heart disease. These studies have all been based on 8-12 years of follow-up. 
 
Because no firm conclusion concerning the relation between elevated cholesterol and the risk of CHD among 
older persons can be drawn from these studies, the efficacy of screening the elderly for elevated cholesterol 
levels remains questionable. One possible explanation for the mixed results is that these previous studies may 
have been limited due to their outcome measures of angina or mortality. These crude measures could have 
allowed for misclassification bias, either random (unbiased) or biased. 
 
Therefore, to reduce the chance of these biases, information on the degree of coronary occlusion obtained from 
angiography studies of patients undergoing coronary arteriography was utilized to study age-specific cholesterol 
associations. With this more detailed and accurate assessment of the severity and extent of disease, further light 
is shed on the possible differences in the importance of plasma cholesterol levels for predicting coronary artery 




The study sample comprised 2544 white men entered in the Milwaukee Cardiovascular Data Registry from 
1977 to 1986 following coronary angiography at St Luke's Hospital or Zablocki VA Medical Center in 
Milwaukee. The arteriography was performed as described by Sones and Shirey [22] or Judkins [23] and the 
films were reviewed independently by a cardiologist and radiologist. Their interpretations were made blind to 
knowledge of risk factors and were recorded on standardized forms. The degree of coronary occlusion was 
measured as suggested by Rowe et al. [24], except that the scale was inverted. Therefore, patients with no 
occlusion were assigned a score of 0, and patients with complete occlusion of the three main coronary arteries 
(right, left anterior descending, and circumflex) were assigned a score of 300. 
 
Risk factor data 
At the time of angiography, patients were requested to complete a comprehensive questionnaire detailing 
medical history and potential risk factors for CHD. Information collected included smoking history, history of 
hypertension or diabetes, alcohol consumption, and anthropometric measures including height and weight. In 
addition, fasting blood samples were drawn prior to angiography and analyzed for cholesterol and triglyceride 
content. Plasma levels of cholesterol and triglycerides were measured with automated procedures [25-27] in a 
laboratory that has been standardized and is monitored by the Centers for Disease Control. Smoking history, 
both past and present was combined into a 5-point scale taking into account both intensity and duration of the 
habit, with 1 representing no smoking and 5, two packs or more per day for at least 20 years [28]. 
 
Statistical analyses 
Several statistical methods were employed to assess the relationship of independent risk factors with occlusion 
score for the entire study sample and within age strata. Descriptive statistics were calculated for variables within 
age-specific strata and for the entire study cohort. Spearman and Pearson correlations were calculated for risk 
factors with both age and occlusion score for the entire group; within each age-specific stratum, correlations 
were computed for each risk factor with occlusion score. Full-factorial analyses of variance were used to assess 
interactions between risk factors and age to predict occlusion, and between risk factors themselves while 
controlling for age. Risk factors that were measured on a continuous scale were coded into quintiles with 
cutpoints based on the entire study sample. 
Multivariable linear regression models were constructed within each age-specific stratum to assess the 
importance of each risk factor in predicting occlusion score independent of other risks. Models were constructed 
with cholesterol levels and age coded as continuous variables and alternatively as indicator variables for quin-
tiles or 10-year age groups. Similarly, other potential confounders were entered into the model as continuous 
variables or indicators for categories. A final model was constructed for the entire sample entering age, 
cholesterol, and the interaction between the two as continuous variables. Potential confounders of the 
cholesterol—occlusion relationship were similarly entered as continuous variables when possible. Within age-
specific strata, similar models were constructed, with the exception of the addition of the interaction terms for 
age and cholesterol. These terms did not add significantly to the models within age strata. Because of the large 
sample size, alpha levels for statistical significance were set at p < 0.01 for analyses of the entire sample. 
Marginal significance was deemed to be 0.01 <p <0.10. 
 
RESULTS 
Characteristics of the study sample are shown in Table l. The average age of these men was 57 ± 9 years (mean 
± SD). Occlusion scores for the sample ranged from 0 to 295 with a mean of 136 ± 82. Plasma cholesterol 
levels ranged from 95 to a high of 506 mg/dl with a mean of 223 ± 46 mg/dl. Stratifying by 5-year age groups, 
the mean occlusion score was generally higher in successively older age groups, ranging from 91 ± 81 in the 25-
35-year-olds to 152 ± 80 in the men aged 66-70 years. Fifteen percent of the study sample had occlusion scores 
of 0, and the proportion generally decreased with age, 35% in the youngest group to 13% in the oldest. 
Cholesterol levels, on the other hand, increased from 223 ± 62 in the 25-35-year-olds to 237 ± 47 in the men 
aged 41-46 years and then decreased successively to 212 ± 48 mg/dl in men aged 71-84 years. The proportion 
of persons with diabetes and hypertension generally increased with age while body mass index (BMI) differed 
little among age groups. 
 
Table 2 presents the bivariate associations of risk factors with occlusion score. For brevity, only the Spearman 
correlations are presented as not all associations measured could be assumed to come from a bivariate normal 
distribution, and Pearson correlations yielded similar results.  
 
For the entire sample, the strongest association with occlusion lies with cholesterol levels with a Spearman 
correlation coefficient of 0.15 (p < 0.01). Smoking history, triglyceride levels, and report of hypertension or 
diabetes were all significantly associated with occlusion, whereas BMI showed no association. Alcohol intake 
was inversely associated with occlusion (p < 0.01). 
 
 
The age-specific correlations are presented in Table 3. For both total cholesterol and triglyceride levels, the 
association with occlusion is weaker in older age groups. Cholesterol levels are highly correlated with occlusion 
in the youngest age group (rs = 0.42, p <0.01). This association is diminished in the 511-55-year-olds (rs = 
0.18, p < 0.01), and falls to a non-significant 0.01 in men aged 70-84 years. The association between 
triglycerides and occlusion shows a similar pattern, with a correlation of 0.40 (p < 0.05) in the 26-35-year-olds, 
0.16 in the 51-55-year-olds and 0.05 in the 70-84-year-olds. BMI showed no clear pattern of association with 




In examining the relationship between age, cholesterol, and occlusion score jointly, the interaction between age 
and cholesterol level was found to be marginally significant by analysis of variance (F = l.76, p <0.03), with 
age blocked in 10-year age groups and cholesterol levels in quintiles. The stereogram in Fig. 1 depicts this 
changing relationship across the five age- and cholesterol level- specific strata. In general, occlusion increases 
with age and with cholesterol level. However, in the older age groups, the relationship between cholesterol and 
occlusion is attenuated. 
 
 
This can be seen again in the multivariable analysis presented in Table 4. For the entire study sample, the 
unadjusted regression coefficient for plasma cholesterol in predicting occlusion score is 0.267. Adjusting the 
model for triglyceride level, BMI, alcohol intake, smoking history, year of catheterization, age, age
2
, and report 
of diabetes or hypertension modifies the coefficient slightly to 0.242. The model explains 8.8% of the variation 
in occlusion for the sample. When the interaction between age and cholesterol level is added, the multiple 
coefficient of determination increases to 0.092, of which 23% can be attributed to the addition of cholesterol 
and its interaction with age to the model. The interaction term for age and cholesterol proved highly significant 
(b = —0.0127, p < 0.001) and must be included in interpreting the adjusted coefficient for the entire sample. 
For example, at the mean age of 57.3 years, the effective coefficient for cholesterol level, including the 
interaction term, becomes 0.24. At age 40, the coefficient is 0.46; at age 70, 0.076. 
 
When stratified by age, the changing association is quite evident. The coefficient for cholesterol is the largest in 
the 40-50-year-olds for both the crude bivariate association and after adjustment for other risk factors. In 
successively older age groups, a unit increase in cholesterol level is predictive of smaller increases in occlusion 
score. The adjusted coefficient ranges from 0.525 in the 40-50-year-olds, to 0.098 in the men aged 70-83 years. 
Similarly, cholesterol levels become less predictive of occlusion score in successively older age groups. In the 
40-50-yearolds, the entire model has a multiple coefficient of determination of 0.174, of which 0.066 is 
contributed by the addition of cholesterol to the model. The magnitude of change in R
2
 diminishes in older age 
groups, to 0.014 in the 60-70- year-olds and to 0.003 (4.2% of the entire model) in the oldest age group. 
 
DISCUSSION 
The present study demonstrates clearly that .the cross-sectional relationship between total cholesterol and 
coronary occlusion diminishes With age. There is less occlusion per unit in crease in cholesterol levels in 
successively older age groups. Further, assuming a linear model, the strength of the association between 
cholesterol and occlusion also diminishes. That is to say, cholesterol becomes less predictive of occlusion in 
older age groups. This change in relationship, however, must be explored further so as to ascertain its 
importance. 
 
The results of this study are not unlike those observed in other studies. The Framingham, Busselton, and Los 
Angeles studies all found that cholesterol levels were less predictive of CHD in older as compared to younger 
age groups [3-10]. However, these results differed from some other studies that found either no relation [16], an 
increase in risk conferred by cholesterol levels in older age groups [17-20], or a slight decrease in risk [21]. 
These discrepant findings could be due to imprecise outcome measures used. CHD is usually a continuous 
developmental process of atherosclerosis and/or thrombosis, as opposed to a simple dichotomy. In studies based 
on outcomes of CHD mortality or clinical manifestations, there may be room for noise to enter statistical 
models [29]. The present study allows for the examination of the role of plasma cholesterol levels with a 
potentially direct measure of the continuous process of atherosclerotic heart disease. This measure, however, is 
not without problems owing to the possibility of remodelling in diseased and collateral vessels. 
 
Although the results of this investigation provide strong evidence for a modification of the relationship between 
cholesterol levels and occlusion owing to age, the etiologic importance of this effect can be debated. It has been 
suggested that the change may not be due to a change in the biological effect of cholesterol in the disease 
process, but may be artifact owing to the cumulative effect of other factors in the aged [30], with cholesterol 
being one component cause of several sufficient causes of CAD [31]. If the number of sufficient causes lacking 
cholesterol as a component increased with age, cholesterol would appear to lose strength as a causative agent. 
Another alternative explanation is that the observed change in relationship may reflect a "harvesting effect".  
Men who are prone to elevated cholesterol levels and subsequently overt CHD may be dying sooner than others. 
As a consequence, the surviving men in the older age groups may not be representative of all men initially at 
risk in this and other studies. That is to say that there may be another form of hypercholesterolemia that is not 
associated with CAD. It may be that the coronary arteries in the aged are less susceptible to the atherogenic 
effects of cholesterol. Conversely, the composition of lipoproteins may be different among the aged secondary 
to dietary or metabolic changes; these lipoproteins may be less atherogenic. As men who have the atherogenic 
form may succumb to their disease early, the remaining men are not at the same risk of death from CHD.  
Further, the surviving men are at greater risk of death due to other causes compared to younger men and thus 
may be removed from subsequent followup due to competing risks. Alternatively, the non-atherogenic 
hypercholesterolemia may be of late-onset and may not be identifiable at younger ages. As this study is based 
on cross-sectional data, we cannot determine whether or not the elevated cholesterol levels represent a lifelong 
pattern, or a late-onset form of abnormality. Simply put, the observed change of effect in this study may be due 
to a selection artifact in the population rather than physiological change. In addition, because there is more 
disease among the aged (i.e. higher occlusion scores) any association may appear to be decreased for arithmetic 
reasons secondary to less variability in occlusion score. This could also play a role in the diminished association 
between triglycerides and occlusion score among the older age groups as well. 
 
Another factor that must be taken into account when interpreting these results is that this study sample is 
probably not representative of the general population [29]. The study sample is drawn from patients referred to 
two medical centers for cardiac catheterization and imaging. Preferential referral of certain patients could result 
in a distortion of the measure of effect. Young men may have been more likely to have been referred for 
catheterization if they had elevated cholesterol as compared to older men with otherwise similar indications. 
This could result in an inflation of the correlation coefficients in the younger age groups, but should not impact 
the functional relationship (regression coefficients) between cholesterol levels and CAD. In these regards, 
cholesterol levels, in this study sample generally decreased across groups with advancing age, in direct 
opposition to population trends [32]. The mean cholesterol level for the youngest age groups fell near the 
eightieth percentile of the white males screened in the Lipid Research Clinics Prevalence Study, while 
successively older age groups neared the median. However, this sample did show some characteristics that 
would be expected in the general population. In general, the proportion of patients reporting hypertension or 
diabetes increased with age. Similarly, the amount of CAD as measured by occlusion score increased with age. 
It should be noted that cholesterol levels were positively associated with disease for all patients and within age 
strata as in population-based studies. Further, for the subset of men having had the HDL subfraction measured, 
the inverse relationship between HDL-cholesterol levels and occlusion remained predictive for all age strata as 
in previous studies [6, 10] (data not shown). Therefore, it does not appear that the men in this study were 
atypical with respect to relationships between total cholesterol and CHD. 
 
Barrett-Connor has suggested the possibility of a shift in risk factor distribution in recent years, such that 
persons with high levels of risk factors are no longer weeded out through selective mortality by age 50 or 65 
[21]. The evidence presented herein would contradict this conclusion. There is a definite decrease in importance 
of total cholesterol levels in predicting coronary occlusion. Further, there was no interaction between year of 
catheterization and cholesterol level in predicting occlusion (data not shown). That is to say that the age-specific 
relationships between cholesterol levels and coronary occlusion did not change within the time frame of this 
study. 
 
If the weight of evidence presented herein and from other studies is accepted to indicate a decrease in relative 
risk of CAD for a given level of plasma cholesterol in older age groups, this attenuated risk should be taken into 
account for individual patients in determining intervention strategies. Perhaps, it may be more appropriate to 
evaluate patients for elevated levels of cholesterol in terms of relative cutpoints [2], based on age-specific lipid 
levels, rather than the current absolute cutpoints across all age groups. However, it should also be remembered 
that a smaller increase in relative risk in the elderly could still represent a substantial increase in absolute risk as 
the incidence of CHD is so great. Further, as noted by Epstein, while predictive power may be lost with total 
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